Patents by Inventor Stephen Edward Connor

Stephen Edward Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Downstream Processing of an Alkaline Phosphatase
    Publication number: 20200063112
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Application
    Filed: September 4, 2019
    Publication date: February 27, 2020
    Applicant: AM-Pharma B.V.
    Inventors: Luigi Johannes Cornelius JONK, Stephen Edward CONNOR, Erik Jan VAN-DEN BERG, Andrea VAN ELSAS, Abhinav Alok SHUKLA, Heather Bethea HORNE, Susan COOK, Timothy Martin KELLY, Victoria Anne DOWLING, Mialy Fanjamalala RAMAROSON
  • Downstream processing of an alkaline phosphatase
    Patent number: 10570380
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: February 25, 2020
    Assignee: AM-PHARMA B.V.
    Inventors: Luigi Johannes Cornelius Jonk, Stephen Edward Connor, Erik Jan Van Den Berg, Andrea Van Elsas, Abhinav Alok Shukla, Heather Bethea Horne, Susan Cook, Timothy Martin Kelly, Victoria Anne Dowling, Mialy Fanjamalala Ramaroson
  • Material and method of fabrication therefor
    Patent number: 8293630
    Abstract: The present invention concerns new methods of fabricating a silicon material comprising phosphorus. The methods allow high levels of phosphorus to be combined with the silicon. In one aspect of the invention a sample of phosphorus is surrounded with a sample of silicon. At least some of the phosphorus is then vaporised and caused to interact with the silicon.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: October 23, 2012
    Assignee: Psimedica Limited
    Inventors: John Joseph Dunkley, Brett Telford, Stephen Edward Connor
  • Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
    Patent number: 6123948
    Abstract: Fusion polypeptides and aggregates of polypeptides comprising papillomavirus-derived antigens, and compositions thereof and their use e.g. with adjuvants for immunogenic and vaccine purposes in eliciting e.g. HPV-specific immune responses. The polypeptides can be purified to result in aggregates which when in solution or dispersion can pass through a sterilisation filter, and in amorphous aggregates. An example of such a polypeptide is a fusion protein of human papillomavirus proteins L2 and E7.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: September 26, 2000
    Assignee: Cantab Pharmaceuticals Research Limited
    Inventors: Nigel Richard Whittle, Jeremy Paddon Carmichael, Stephen Edward Connor, Henry Stephen Grammer Thompson, Mark Jonathan Wilson
  • Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
    Patent number: 5955087
    Abstract: Fusion polypeptides and aggregates of polypeptides comprising papillomavirus-derived antigens, and compositions thereof and their use e.g. with adjuvants for immunogenic and vaccine purposes in eliciting e.g. HPV-specific immune responses. The polypeptides can be purified to result in aggregates which when in solution or dispersion can pass through a sterilisation filter, and in amorphous aggregates. An example of such a polypeptide is a fusion protein of human papillomavirus proteins L2 and E7.
    Type: Grant
    Filed: February 23, 1996
    Date of Patent: September 21, 1999
    Assignee: Cantab Pharmaceuticals Research Limited
    Inventors: Nigel Richard Whittle, Jeremy Paddon Carmichael, Stephen Edward Connor, Henry Stephen Grammer Thompson, Mark Jonathan Wilson